Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Female researcher in lab with tool.

    New “Off” Medication Submitted to FDA

    An under-the-tongue, dissolvable medication for “off” time, when Parkinson’s symptoms return, now is at the FDA.
    Learn more

  • Foundation Honors Three Distinguished Scientists with Our 2019 Major Research Prizes

    MJFF honored three researchers for their groundbreaking work to speed critical advances in Parkinson's disease and dystonia research on November 16, 2019, in New York City.
    Learn more
  • Samples in the lab.

    Protective Genetic Mutation Discovered in Alzheimer’s

    A new report in the New York Times illustrates how studying genetics can help not only to better understand the causes and progression of brain diseases such as Alzheimer’s and Parkinson’s, but to…
    Learn more
  • Theresa Lin, Sarah Simon, Katherine Leaver, Sonya Elango, Susan Bressman, Deborah Raymond, Rachel Saunders-Pullman

    Research Community Thanks Parkinson’s Study Participants

    Research volunteers advance understanding and treatment of Parkinson’s disease. Foundation staff and partners recently thanked local participants.
    Learn more
  • When Life Gives you Parkinson's

    ‘When Life Gives You Parkinson’s’: Podcast Talks to MJFF about Deep Brain Stimulation

    The latest "When Life Gives You Parkinson's" episode posed the question — “Deep Brain Stimulation, Is It Worth It?” — and covered research on DBS and the experiences of people living…
    Learn more
  • Female researcher pipetting in the lab.

    Research Roundup: New Gene Therapy Trial Begins Recruiting

    Prevail Therapeutics is now recruiting for Propel, its clinical trial of a gene therapy to treat Parkinson’s disease in people with GBA mutations.
    Learn more
  • MJFF Working Together

    A Prescription for Brain Disease Research

    In this essay for the Milken Institute, Michael J. Fox Foundation CEO Todd Sherer, PhD, calls for community and transparency to drive brain disease research.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year